Who are Solarea Bio's investors?

Solarea Bio's investors include Olive Tree Capital, Rising Tide, Bold Capital Partners, DigitalDx Ventures, GISEV Family Office, S2G Investments, Viking Global Investors.

How much funding has Solarea Bio raised?

Solarea Bio has disclosed $37.2M raised across 4 rounds.

Where is Solarea Bio headquartered?

Solarea Bio is headquartered in Waltham, US.

Solarea Bio

Waltham, US · Founded 2017 · Delaware corporation · 9 known investors

Find your way into Solarea Bio

Solarea Bio develops plant-sourced living synbiotics (probiotics plus prebiotics) as medical foods targeting inflammatory conditions, starting with bone loss in women with osteopenia. Its clinically tested products aim to address underserved conditions such as osteopenia and rheumatoid arthritis.

Biotech Healthtech Wellness & Fitness

Founders & leadership

ILISSA LARIMOREExecutive

GERARDO TOLEDONamed on SEC filing

ERIC SCHOTTNamed on SEC filing

Board

ANULA JAYASURIYA inBoard directorInvestor at DigitalDx Ventures

MATTHEW WALKER inBoard MemberManaging Director at S2G Investments

NEAL BHADKAMKAR inBoard directorGeneral Partner at Bold Capital Partners

GREGORY SIECZKIEWICZBoard director

Investors · 9

Olive Tree CapitalBoston

Rising TidePacifica

Bold Capital Partnersreported · 3 sourcesSanta Monicavia Neal Bhadkamkar · board

DigitalDx VenturesreportedMenlo Parkvia Anula Jayasuriya · board

GISEV Family OfficereportedMilan

S2G Investmentsreported · 2 sourcesChicago · $1M – $5M

Viking Global InvestorsreportedStamford

Also in the syndicate · 2

GG 1978 SICAF SIFViking Global

Reported raises · per SEC filings

Form D private placements

$37.2M disclosed across 4 rounds · 2020–2025

▶$9.9MraisedNov 2025 · 5 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

NEAL BHADKAMKARDirector
MATTHEW WALKERDirector
ANULA JAYASURIYADirector
GREGORY SIECZKIEWICZDirector
CATHERINE BALSAM-SCHWABERExecutive Officer, Director
ERIC SCHOTTExecutive Officer

Amount sold: $9.9M
First sale: Nov 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1MraisedSep 2024 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

ANULA JAYASURIYADirector
MATTHEW WALKERDirector
NEAL BHADKAMKARDirector
ILISSA LARIMOREExecutive Officer
GREGORY SIECZKIEWICZDirector
GERARDO TOLEDOExecutive Officer, Director
ERIC SCHOTTExecutive Officer

Amount sold: $1M
First sale: Aug 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$15MraisedMay 2023 · 4 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

ANULA JAYASURIYADirector
GREGORY SIECZKIEWICZDirector
MATTHEW WALKERDirector
GERARDO TOLEDOExecutive Officer, Director
NEAL BHADKAMKARDirector
ERIC SCHOTTExecutive Officer

Offering amount: $25M
Amount sold: $15M
First sale: May 2023
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$11.3MraisedSep 2020 · 15 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

GREGORY SIECZKIEWICZDirector
GERARDO TOLEDOExecutive Officer, Director
ERIC SCHOTTExecutive Officer
MATTHEW WALKERDirector
NEAL BHADKAMKARDirector
ANULA JAYASURIYADirector

Offering amount: $14.8M
Amount sold: $11.3M
First sale: Aug 2020
Incorporated: Corporation, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Solarea Bio Appoints New Chief Executive Officer - BioSpacebiospace.com · Oct 2025

Solarea Bio raises $15M in series B funding roundnutraingredients.com · May 2023

Solarea Bio, a biotech company that creates therapeutic medical foods from beneficial microbes, raises $15 million - Global Wellness Summitglobalwellnesssummit.com · May 2023

Solarea Bio Announces Series A Financing Led by S2G Ventures and Bold Capital Partnersprnewswire.com · Oct 2020

Frequently asked questions

What does Solarea Bio do?: Solarea Bio develops plant-sourced living synbiotics (probiotics plus prebiotics) as medical foods targeting inflammatory conditions, starting with bone loss in women with osteopenia. Its clinically tested products aim to address underserved conditions such as osteopenia and rheumatoid arthritis.
Who are Solarea Bio's investors?: Solarea Bio's investors include Olive Tree Capital, Rising Tide, Bold Capital Partners, DigitalDx Ventures, GISEV Family Office, S2G Investments, Viking Global Investors.
How much funding has Solarea Bio raised?: Solarea Bio has disclosed $37.2M raised across 4 rounds.
Where is Solarea Bio headquartered?: Solarea Bio is headquartered in Waltham, US.